Ingevity's third quarter net sales decreased by 7% compared to the prior year, with weak industrial demand impacting Advanced Polymer Technologies and Industrial Specialties. Net income and EPS also decreased. However, the company maintained mid-twenties adjusted EBITDA margins due to its specialty businesses and cost reduction actions.
Net sales decreased 7% to $446.0 million compared to a record prior year.
Net income decreased to $25.2 million, with diluted EPS of $0.69; adjusted earnings were $44.2 million, with diluted adjusted EPS of $1.21.
Adjusted EBITDA decreased to $110.4 million, with an adjusted EBITDA margin of 24.8%.
Operating cash flow was $106.9 million, with free cash flow of $73.4 million.
The company reduced its full-year adjusted EBITDA guidance to between $375 million and $390 million due to weak industrial demand, pricing pressure, and rising CTO costs in the fourth quarter.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance